Natural killer cells company teams up with TCD
The Irish Times – View full story
Maximizing synergy and mitigating resistance: novel dual-targeted natural killer cell therapies for cancer
Nature BioPharma Dealmaker – View full story
Mulligan backs ONK Therapeutics in $8m funding
The Irish Times – View full story
CAR-plus: Irish biotech recruits Kite alum Chris Nowers to prep dual-targeting NK cell therapy for the clinic
Endpoints – View full story
